Pathmaker Neurosystems
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Boston Pl Ste 2600, Boston, Massachuse...Phone Number
(617) 535-7696Website
www.pmneuro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pathmaker Neurosystems
PathMaker Neurosystems is a clinical-stage neuromodulation company focused on developing non-invasive devices to treat ALS and other serious neurological disorders. The company aims to commercialize innovative products that suppress neuronal hyperexcitability and activate protein degradation pathways. Utilizing multi-site direct current stimulation technology, PathMaker seeks to restore damaged neural pathways and reduce protein aggregation in motor neurons. Their approach is based on extensive pre-clinical and clinical studies, positioning them at the forefront of a new treatment paradigm for ALS.Explore more
Pathmaker Neurosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pathmaker Neurosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pathmaker Neurosystems had a recent Job posting/layoffs
Product Launch: Get notified when Pathmaker Neurosystems launches new products
Pathmaker Neurosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Pathmaker Neurosystems recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Pathmaker Neurosystems
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Pathmaker Neurosystems is spiking on competitors!
Funding: Get notified immidiatlly once Pathmaker Neurosystems has new funding data
Check if Pathmaker Neurosystems has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Pathmaker Neurosystems
Find 3 more new buyers
Compare Similar Companies to Pathmaker Neurosystems
Compare insights from companies similar to Pathmaker Neurosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pathmaker Neurosystems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pathmaker Neurosystems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pathmaker Neurosystems.
Pathmaker Neurosystems financials insights
Gather financial insights about Pathmaker Neurosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$36K
2024
Other Financing Round
$2.2M
Pathmaker Neurosystems Tech Stack
A closer look at the technologies used by Pathmaker Neurosystems
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Funding, Laboratory Operations
Product Launch
Enterprise Software, Legal Affairs, Healthcare Technology
Product Launch
Enterprise Software, Legal Affairs, Healthcare Technology
Product Launch
Enterprise Software, Legal Affairs, Healthcare Technology
Executive Move
Executive Moves, Board of Directors
Pathmaker Neurosystems News & Media
PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS
PathMaker Neurosystems Announces Completion of ALS Early Feasibility Study of the MyoRegulator Device for Non-Invasive Treatment of ALSPathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms
PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Non-Invasive Treatment of ALS Using the MyoRegulator® Neuromodulation DevicePathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation
PathMaker Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive NeuromodulationPathMaker Neurosystems Announces Rhode Island Life Sciences Hub (RILSH) Funding to Establish Operations in Rhode Island
BOSTON, MA and PROVIDENCE, RI, June 02, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS), today announced that it has been selected to receive funding from the Rhode Island Life Sciences Hub (RILSH) to establish a presence in Rhode Island. This strategic expansion represents a significant milestone in PathMaker's growth trajectory and reinfo
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pathmaker Neurosystems
Sign Up For FreeTo access detailed company insights
PathMaker Neurosystems is a clinical-stage neuromodulation company focused on developing non-invasive devices to treat ALS and other serious neurological disorders. The company aims to commercialize innovative products that suppress neuronal hyperexcitability and activate protein degradation pathways. Utilizing multi-site direct current stimulation... Read More
